La cadena de opciones muestra datos clave de las opciones de acciones de Scienture Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Scienture Holdings..

Scienture Holdings (NASDAQ:SCNX) Bolsa, Cadena de Opciones

Scienture Holdings

Trxade Health

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Section,Of,A,Financial,Newspaper,Titled,Key,Movers

Earnings

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADTX

AREB

ASNS

DECK

DVLT

INBX

INEO

INTC

MOFG

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

Qualigen Therapeutics, Inc. - Common Stock

QLGN

SCNX

VIVK

WGRX

YGMZ

Connexa Sports Technologies Inc. - Common Stock

YYAI

El premercado se tiñe de verde con fuertes subidas en tecnología, salud y finanzas tras una oleada de resultados mejores de lo esperado.

Acciones de Intel suben alrededor de un 8%; Aquí están 20 acciones que se mueven en el premercado

Financial,Chart,And,Investment,Graph,Analysis,Stock,On,Tablet,Screen.

Equities

SMCI

Wall Street cerró con avances moderados tras una jornada marcada por los resultados de Intel y el debut farmacéutico de Scienture Holdings.

Intel, Scienture Holdings, Ford, Deckers y Super Micro Computer: 5 acciones que están en el radar de los inversores

Scienture Holdings Inc

Press Releases

Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding

SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.

Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock

SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market

SCIENTURE Secures Multiple Commercial GPO Agreements, Expanding U.S. Market Access for Arbli™ (losartan potassium) to more than 2500 Healthcare Institutions

SCIENTURE Holdings Announces Full Repayment and Conversion of Outstanding Debentures, Strengthening Balance Sheet

Wellgistics Health Announces Executive Management and Board Changes

SCIENTURE'S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers

SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium)

Comments

Scienture Holdings

Scienture Holdings (SCNX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL